181 related articles for article (PubMed ID: 23849563)
1. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
[TBL] [Abstract][Full Text] [Related]
2. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
[TBL] [Abstract][Full Text] [Related]
3. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
[TBL] [Abstract][Full Text] [Related]
4. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
Rolf D; Elsayad K; Eich HT
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
[TBL] [Abstract][Full Text] [Related]
5. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
Chowdhary M; Chhabra AM; Kharod S; Marwaha G
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
[TBL] [Abstract][Full Text] [Related]
6. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
7. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
[TBL] [Abstract][Full Text] [Related]
8. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
[TBL] [Abstract][Full Text] [Related]
9. Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
Harrison C; Young J; Navi D; Riaz N; Lingala B; Kim Y; Hoppe R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e651-7. PubMed ID: 21489711
[TBL] [Abstract][Full Text] [Related]
10. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
11. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in the management of mycosis fungoides: indications, results, prognosis. Twenty years experience.
Kirova YM; Piedbois Y; Haddad E; Levy E; Calitchi E; Marinello G; Le Bourgeois JP
Radiother Oncol; 1999 May; 51(2):147-51. PubMed ID: 10435806
[TBL] [Abstract][Full Text] [Related]
13. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
14. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation.
Maingon P; Truc G; Dalac S; Barillot I; Lambert D; Petrella T; Naudy S; Horiot JC
Radiother Oncol; 2000 Jan; 54(1):73-8. PubMed ID: 10719702
[TBL] [Abstract][Full Text] [Related]
16. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.
An Y; Jiang W; Andraos TY; Reddy JP; Yehia ZA; Lloyd S; Duvic M; D'Souza NM; Milgrom SA; Pinnix CC; Oki Y; Smith GL; Wilson LD; Dabaja BS
Radiother Oncol; 2019 Feb; 131():88-92. PubMed ID: 30773193
[TBL] [Abstract][Full Text] [Related]
18. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
[TBL] [Abstract][Full Text] [Related]
19. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
20. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
